EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Antiphospholipid Syndrome: A Review

Md. Motahar Hossain, Md. Akhter Hossain, Yasmin Rahman, Md. Kamrul Hasan

Haematology Journal of Bangladesh · 2020

DOI: 10.37545/haematoljbd201824 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Haematology Journal of Bangladesh, 2020. Verfasst von Md. Motahar Hossain und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antiphospholipid syndrome (APS) is an autoimmune disease characterized by venous thromboembolism, arterial thrombosis, and obstetric morbidities in the setting of persistently positive levels of antiphospholipid antibodies. It may be primary or secondary. The latest classification criteria (Sydney 2006) recognize just three tests to define this syndrome- lupus anticoagulant, anticardiolipin antibodies and anti-?2-glycoprotein-1 antibodies. Treatment of thrombotic events involves lifelong anticoagulation with vitamin K antagonist warfarin. Antiphospholipid antibody syndrome (APS) with only pregnancy morbidity is treated with thromboprophylaxis with heparin during pregnancy and postpartum for 6 weeks. In this review we discuss the pathogenesis, diagnosis, treatment and prognosis of the APS.

Zitieren

APA

Hossain, M. M., Hossain, M. A., Rahman, Y., & Hasan, M. K. (2020). Antiphospholipid Syndrome: A Review. Haematology Journal of Bangladesh. https://doi.org/10.37545/haematoljbd201824

Vancouver

Hossain MM, Hossain MA, Rahman Y, Hasan MK. Antiphospholipid Syndrome: A Review. Haematology Journal of Bangladesh. 2020. doi:10.37545/haematoljbd201824

BibTeX
@article{Hossain2020,
  author = {Hossain, Md. Motahar and Hossain, Md. Akhter and Rahman, Yasmin and Hasan, Md. Kamrul},
  title = {Antiphospholipid Syndrome: A Review},
  journal = {Haematology Journal of Bangladesh},
  year = {2020},
  doi = {10.37545/haematoljbd201824}
}
Kostenlos starten →